Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06458530 · ClinicalTrials.gov registry record · NA

Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.

A NA study of PreDiabetes and Muscle Weakness, sponsored by Impactiv.

Active
Registry status
NA
Development phase
74
Enrollment target
1
Study location

NCT06458530 is a NA study of PreDiabetes and Muscle Weakness that is active but no longer recruiting, run by Impactiv. The registered enrollment target is 74 participants, below the 690-participant average among 89 other PreDiabetes trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06458530, a NA study of PreDiabetes and Muscle Weakness, is active but no longer recruiting, sponsored by Impactiv.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control.

Interventions

  • BEHAVIORAL Vivo

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2024-07-09
Est. Completion 2026-03-31
Phase NA

Sponsor

Impactiv

1 total trials

What the Registry Record Tells You About NCT06458530

The ClinicalTrials.gov registry entry for NCT06458530 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 690-participant average among 89 other PreDiabetes trials with a reported enrollment target (89% lower). The listed sponsor is Impactiv, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Vivo is the first listed.

NCT06458530 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06458530 about?

NCT06458530 is a clinical study titled "Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.". This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control.

What is the current status of trial NCT06458530?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2024-07-09. Estimated completion is 2026-03-31.

What conditions does trial NCT06458530 study?

This clinical trial studies the following conditions: PreDiabetes, Muscle Weakness, Muscle Loss, Older Adult.

What interventions are being tested in trial NCT06458530?

The interventions under investigation include: Vivo (BEHAVIORAL).

Who is sponsoring clinical trial NCT06458530?

This trial is sponsored by Impactiv, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06458530 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.